書誌情報
WS2-2. BORTEZOMIB / MELPHALAN / PREDNISONE (VMP) +- DARATUMUMAB (D) IN NDMM : JAPANESE COHORT OF ALCYONE
Tomoaki Fujisaki1, Mateos Maria-Victoria2, Meletios A Dimopoulos3, Kenshi Suzuki4, Sung-Soo Yoon5, Christopher Chiu6, Jianping Wang7, Robin Robin8, Wendy Crist6, William9, William Deraedt9, Huong Nguyen7, Ming Qi6, Jesus San-Miguel10
1Matsuyama Red Cross Hospital, 2University Hospital of Salamanca / IBSAL, 3National and Kapodistrian University of Athens, 4Department of Hematology, Japanese Red Cross Medical Center, 5Department of Internal Medicine, Seoul National University College of Medicine, 6Janssen Research and Development, LLC, 7Janssen Research & Development, LLC, 8Janssen Biotech, 9Janssen Research & Development, LLC, 10Clinica Universidad de Navarra-CIMA, IDISNA, CIBERONC
International Journal of Myeloma 8(2): 84-84, 2018.
個人会員・法人会員の方（IDが5または10で始まる方）
- 全文ダウンロード： 従量制、基本料金制の方共に121円(税込) です。
